Laurantis Pharma Oy

Laurantis is a clinical-stage specialty pharmaceutical development company formed through the merger of two independent companies, BioCis Pharma Oy and Oy Lx Therapies Ltd in late 2010. Laurantis has a broad portfolio of first-in-class products based on two proprietary technologies. The Company’s lead products target the treatment of a variety of inflammatory diseases and conditions including atopic dermatitis, dry eye syndrome, interstitial cystitis, and lymphatic disorders, as well as the treatment of bladder cancer.

Priaxon AG

Priaxon, based in Munich, Germany, is a drug development company focused on small molecule therapeutics inhibiting protein-protein interactions. The company employs a unique combination of proprietary chemoinformatic tools and innovative synthetic chemistry to rationalize and accelerate the drug discovery process. Priaxon's lead projects include an inhibitor of the Mdm2-p53 interaction and a multi-action antibiotic compund. 


www.priaxon.com

Medtentia International Ltd Oy

Medtentia is a Finnish medtech company developing novel mitral valve repair products based on the company’s proprietary helix concept. Medtentia’s mitral valve repair products, including a novel annuloplasty ring, have the potential to significantly reduce the invasiveness, operation time and morbidity currently associated with mitral valve repair and replacement operations.

www.medtentia.com

Medeia Therapeutics Oy

Medeia Therapeutics Oy is a drug discovery company focused on novel therapeutics for neurodegenerative diseases. Medeia’s discovery platforms are centered on the expertise of Medeia’s scientific founders in the field of molecular medicine and include programs based on both small molecule and cell therapy approaches. Medeia has partnered its lead small molecule program with Orion Corporation.

www.medeiatherapeutics.com

Onbone Oy

Onbone (ex Injectobone) is a Finnish medtech company established in 2008. Onbone’s business idea is to develop and manufacture innovative medical devices for orthopedics and traumatology. The company has two product lines under development: biodegradable bone cement, BIOCEMENT™ and reshapable, ecological cast product, OMNICAST™. Both product lines are based on Onbone’s proprietary biomaterial inventions.

www.onbone.com

miacom Diagnostics GmbH

miacom is a German diagnostic company developing kits for the rapid identification of pathogens from stool, sputum and blood samples. miacom’s technology is based on a proprietary advancement of the FISH technology. miacom's technology offers a simple, affordable and fast alternative to the current culture or PCR-based products.


www.miacom-diagnostics.com